Lynx Investment Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-31
Closed -$32.6K 629
2024
Q2
$32.6K Buy
+31
New +$32.6K 0.02% 285